MTOR and cancer: Still, its binding with PD-1 seems to initiate a cascade of signals in cancer cells that induces a decreased resistance to some forms of apoptosis, reducing the activity of both mTOR and glycolytic metabolism that protects against the cytotoxic effect of interferons I and II and cytolysis mediated by cytotoxic T lymphocytes.